Clofarex clofarabine: The companies began 2 U.S. open-label Phase II clinical trials of clofarabine in pediatric patients with relapsed or refractory ALL and AM

Bioenvision Inc. (BIOV), London, U.K. Ilex Oncology Inc. (ILXO), San Antonio, Texas Product: Clofarex clofarabine Business: Cancer Therapeutic category: Cell proliferation Target: DNA Description: N...